SCHEMBL9599183

SCHEMBL9599183

O=Cc1cccc(OCc2ccc3ccccc3c2)c1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.55
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ERN1 O75460 4/20 0.48
TLR2 O60603 2/20 0.48
TLR1 Q15399 1/20 0.48
TLR6 Q9Y2C9 1/20 0.48
CAPN1 P07384 1/20 0.47
PTGER3 P43115 1/20 0.45
SPHK2 Q9NRA0 1/20 0.44
SPHK1 Q9NYA1 1/20 0.44
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43
CCNB1 P14635 1/20 0.43
CCND1 P24385 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
PPARG P37231 1/20 0.43
TLR4 O00206 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13460592 0.90 RAB9A (0.50) RAB9AKMT2ATDP1L3MBTL1ERN1
SCHEMBL986050 0.83 CCNB2 (0.62) TDP1L3MBTL1ERN1TLR2TLR1
SCHEMBL31683746 0.83 CCNB2 (0.62) TDP1L3MBTL1ERN1TLR2TLR1
SCHEMBL9597698 0.82 RAB9A (0.52) RAB9AKMT2ATDP1L3MBTL1ERN1
SCHEMBL19511901 0.80 ERN1 (0.60) RAB9ATDP1ERN1TLR2TLR1
SCHEMBL31533115 0.79 MAPT (0.56) RAB9AKMT2ATDP1L3MBTL1ERN1
SCHEMBL415678 0.79 MAPT (0.56) RAB9AKMT2ATDP1L3MBTL1ERN1
SCHEMBL9599135 0.79 RAB9A (0.49) RAB9AKMT2ATDP1L3MBTL1TLR2
SCHEMBL31307781 0.77 KMT2A (0.56) RAB9AKMT2ATDP1L3MBTL1PTGER3
SCHEMBL10854605 0.76 APP (0.60) RAB9ACAPN1SPHK2SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5196422-A Antiinflammatory agents, antiallergens ICI PHARMA (FR) 1993-03-23 US disclosed
US-5089513-A Antiinflammatory agents; antiallergens; asthma; side effect reduction ICI PHARMA (FR) 1992-02-18 US disclosed